Leveraging Administrative Health Data to Capture Rare Adverse Drug Reactions: Identifying Pediatric Patients With Trimethoprim‐Sulfamethoxazole Acute Respiratory Distress Syndrome
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 17.06.2026. Verfasst von Keith Feldman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Trimethoprim, Sulfamethoxazole Drug Combination, Respiratory Distress Syndrome, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of General Medical Sciences.
Abstract (Originalsprache)
Rare adverse drug reactions (ADRs) are underrecognized and underreported in the electronic medical record (EMR). These events often require clinical review, making systematic identification challenging. The study aim was to develop an approach to prioritize identification and validation of a rare ADR to trimethoprim‐sulfamethoxazole causing acute respiratory distress syndrome (TMP‐SMX ARDS) across medical institutions. We developed a clinical phenotype based on 2 local TMP‐SMX ARDS cases mapped to standardized elements of a national comparative healthcare database (PHIS). We validated identification of TMP‐SMX ARDS at scale across medical institutions. A set of scoring criteria was created to prioritize cases and generate a center‐specific top 10 list of candidate encounters. External validation at 3 PHIS contributing hospitals with a known TMP‐SMX ARDS case was performed by reviewing the top 10 candidate list for the known case. The review period was January 1, 2012–January 1, 2025. EMR data extracted from 2 TMP‐SMX ARDS cases included patients that both required extracorporeal membrane oxygenation for > 100 days, experienced air leak early in hospital presentation, required tracheostomy placement, and were hospitalized for > 440 days. Based on the TMP‐SMX ARDS phenotype, the local cases ranked 1st and 3rd on the PHIS generated top 10 candidate list for internal validation. For external validation, known cases were identified on their respective hospital top 10 lists, ranking 3rd, 3rd, and 5th. Applying a TMP‐SMX ARDS phenotype to a national health care database paired with clinical review of candidate cases may be an effective approach to identify underrecognized ADRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Pediatrics, University of Missouri - Kansas City, Kansas City, Missouri, USA.
- Division of Critical Care Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA.
- Department of Pediatrics, Division of Critical Care Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Department of Pediatrics, Division of Hospital Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Keith Feldman, James W Antoon, Kevin J Downes, Jennifer L Goldman
Förderung
- NIGMS NIH HHS
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of General Medical Sciences
Zitieren
APA
Feldman, K., Miller, J. O., Doane, K., Loftis, L., Antoon, J. W., Downes, K. J., & Goldman, J. L. (2026). Leveraging Administrative Health Data to Capture Rare Adverse Drug Reactions: Identifying Pediatric Patients With Trimethoprim‐Sulfamethoxazole Acute Respiratory Distress Syndrome. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70289
Vancouver
Feldman K, Miller JO, Doane K, Loftis L, Antoon JW, Downes KJ, et al. Leveraging Administrative Health Data to Capture Rare Adverse Drug Reactions: Identifying Pediatric Patients With Trimethoprim‐Sulfamethoxazole Acute Respiratory Distress Syndrome. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70289
BibTeX
@article{Feldman2026,
author = {Feldman, Keith and Miller, Jenna O and Doane, Katherine and Loftis, Laura and Antoon, James W and Downes, Kevin J and Goldman, Jennifer L},
title = {Leveraging Administrative Health Data to Capture Rare Adverse Drug Reactions: Identifying Pediatric Patients With Trimethoprim‐Sulfamethoxazole Acute Respiratory Distress Syndrome},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70289}
}
EUVIMED